Erratum

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

K. D. Cummins, S. M. Jane, S. Ninkovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Article numbere246
JournalBlood Cancer Journal
Volume4
Issue number9
DOIs
Publication statusPublished - 1 Jan 2014

Cite this

Cummins, K. D. ; Jane, S. M. ; Ninkovic, S. ; Bazargan, Ali ; Filshie, Robin J A ; Sutrave, G ; Hertzberg, Mark ; Scott, A. ; Lane, S. ; Yannakou, C. K. ; Ritchie, Peter D. ; D'Rozario, J. ; Black, J. ; Bavishi, Ketan ; Wei, A. / Erratum : Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59). In: Blood Cancer Journal. 2014 ; Vol. 4, No. 9.
@article{9491910fb6004c698b12e05537595a24,
title = "Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)",
author = "Cummins, {K. D.} and Jane, {S. M.} and S. Ninkovic and Ali Bazargan and Filshie, {Robin J A} and G Sutrave and Mark Hertzberg and A. Scott and S. Lane and Yannakou, {C. K.} and Ritchie, {Peter D.} and J. D'Rozario and J. Black and Ketan Bavishi and A. Wei",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/bcj.2014.68",
language = "English",
volume = "4",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "9",

}

Erratum : Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59). / Cummins, K. D.; Jane, S. M.; Ninkovic, S.; Bazargan, Ali; Filshie, Robin J A; Sutrave, G; Hertzberg, Mark; Scott, A.; Lane, S.; Yannakou, C. K.; Ritchie, Peter D.; D'Rozario, J.; Black, J.; Bavishi, Ketan; Wei, A.

In: Blood Cancer Journal, Vol. 4, No. 9, e246, 01.01.2014.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Erratum

T2 - Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

AU - Cummins, K. D.

AU - Jane, S. M.

AU - Ninkovic, S.

AU - Bazargan, Ali

AU - Filshie, Robin J A

AU - Sutrave, G

AU - Hertzberg, Mark

AU - Scott, A.

AU - Lane, S.

AU - Yannakou, C. K.

AU - Ritchie, Peter D.

AU - D'Rozario, J.

AU - Black, J.

AU - Bavishi, Ketan

AU - Wei, A.

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84927745055&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.68

DO - 10.1038/bcj.2014.68

M3 - Comment / Debate

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 9

M1 - e246

ER -